Recurrent ESR1 mutations activating mutations in breast cancer

被引：0
|
作者：
Jeselsohn, R. [1 ]
机构：
[1] Dana Farber Canc Ctr, Boston, MA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-ES10-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES10-1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer
    Kinslow, Connor J.
    Tang, Ashley
    Chaudhary, Kunal R.
    Cheng, Simon K.
    [J]. JNCI CANCER SPECTRUM, 2022, 6 (05)
  • [22] Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
    Tomás Reinert
    Rodrigo Gonçalves
    José Bines
    [J]. Current Treatment Options in Oncology, 2018, 19
  • [23] ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer
    Jeselsohn, Rinath
    Buchwalter, Gilles
    De Angelis, Carmine
    Brown, Myles
    Schiff, Rachel
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (10) : 573 - 583
  • [24] Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
    Li, Zheqi
    Wu, Yang
    Yates, Megan E.
    Tasdemir, Nilgun
    Bahreini, Amir
    Chen, Jian
    Levine, Kevin M.
    Priedigkeit, Nolan M.
    Nasrazadani, Azadeh
    Ali, Simak
    Buluwela, Laki
    Arnesen, Spencer
    Gertz, Jason
    Richer, Jennifer K.
    Troness, Benjamin
    El-Ashry, Dorraya
    Zhang, Qiang
    Gerratana, Lorenzo
    Zhang, Youbin
    Cristofanilli, Massimo
    Montanez, Maritza A.
    Sundd, Prithu
    Wallace, Callen T.
    Watkins, Simon C.
    Fumagalli, Caterina
    Guerini-Rocco, Elena
    Zhu, Li
    Tseng, George C.
    Wagle, Nikhil
    Carroll, Jason S.
    Jank, Paul
    Denkert, Carsten
    Karsten, Maria M.
    Blohmer, Jens-Uwe
    Park, Ben H.
    Lucas, Peter C.
    Atkinson, Jennifer M.
    Lee, Adrian, V
    Oesterreich, Steffi
    [J]. CANCER RESEARCH, 2022, 82 (07) : 1321 - 1339
  • [25] Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
    Reinert, Tomas
    Goncalves, Rodrigo
    Bines, Jose
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (05)
  • [26] ESR1 mutations provide novel targets for breast cancer immunotherapy.
    Goldberg, Jonathan
    Qiao, Na
    Gross, Brett
    Meric-Bernstam, Fund
    Guerriero, Jennifer
    Chen, Ken
    Philips, Anne, V
    Peoples, George Earl
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists
    Toy, Weiyi
    Weir, Hazel
    Razavi, Pedram
    Lawson, Mandy
    Goeppert, Anne U.
    Mazzola, Anne Marie
    Smith, Aaron
    Wilson, Joanne
    Morrow, Christopher
    Wong, Wai Lin
    De Stanchina, Elisa
    Carlson, Kathryn E.
    Martin, Teresa S.
    Uddin, Sharmeen
    Li, Zhiqiang
    Fanning, Sean
    Katzenellenbogen, John A.
    Greene, Geoffrey
    Baselga, Jose
    Chandarlapaty, Sarat
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 277 - 287
  • [28] Ligand-binding Domain-activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells
    Zinger, Lotem
    Merenbakh-Lamin, Keren
    Klein, Anat
    Elazar, Adi
    Journo, Shani
    Boldes, Tomer
    Pasmanik-Chor, Metsada
    Spitzer, Avishay
    Rubinek, Tami
    Woif, Ido
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2900 - 2914
  • [29] Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
    Guttery, David S.
    Page, Karen
    Hills, Allison
    Woodley, Laura
    Marchese, Stephanie D.
    Rghebi, Basma
    Hastings, Robert K.
    Luo, Jinli
    Pringle, J. Howard
    Stebbing, Justin
    Coombes, R. Charles
    Ali, Simak
    Shaw, Jacqueline A.
    [J]. CLINICAL CHEMISTRY, 2015, 61 (07) : 974 - 982
  • [30] Enrichment of ESR1 mutations in breast cancer cell lines modelling endocrine resistance
    Ribas, Ricardo
    Pancholi, Sunil
    Martin, Lesley-Ann
    Dowsett, Mitch
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 563 - 563
12345